Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
US5190922A · kind A · utility
7Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 1991 |
| Grant date | Mar 2, 1993 |
| Priority date | — |
| Expiry date | Jun 4, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.